Skip to main content
SpringerLink
Log in
SpringerLink
Log in

Neurobiochemische Untersuchungen bei Akut- und Langzeitbehandlung mit Neuroleptika

  • Conference paper
Neuroleptika Rückschau 1952–1986, Künftige Entwicklungen

Part of the book series: Tropon-Symposium ((BAYERZNS,volume 2))

Zusammenfassung

Neurobiochemische Untersuchungen bei der Akut- und Langzeitbehandlung mit Neuroleptika (NL) haben zwei Ziele:

  1. 1.

    Aufklärung des Wirkungsmechanismus der NL.

  2. 2.

    Optimierung der Therapie.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Ackenheil M (1981) Biochemical effects of apomorphine: contribution to schizophrenia research. In: Corsini GU, Gessa GL (eds) Apomorphine and other dopaminomimetics, vol 2. Raven Press, New York, pp 215–224

    Google Scholar 

  • Andén NE (1970) Effects of amphetamine and some other drugs on central catecholamine mechanisms. In: Costa E, Garattini S (eds) Amphetamines and related compounds. Raven Press, New York, pp 447–462

    Google Scholar 

  • Andén NE, Rods BE, Werdenius B (1964) Effects of chlorpromazine, haloperidol and reserpine on the level of phenolic acids in rabbit corpus striatum. Life Sci 3: 149–158

    Article  Google Scholar 

  • Aratö M, Endrös A, Polgar M (1979) Endocrinological changes in patients with sexual dysfunction under long-term neuroleptic treatment. Pharmacopsychiat 12: 426

    Article  Google Scholar 

  • Bowers MB (1973) 5-hydroxyindolacetic acid (5-HIAA) and homovanillic acid (HVA) following probenecide in acute psychotic patients with phenothiazines. Psychopharmacologica 28:309–318

    Article  Google Scholar 

  • Bowers MB, Gold BJ, Roth RH (1980) CSF-Gaba in psychotic disorders. Psychopharmacologica 70: 279–282

    Article  Google Scholar 

  • Bowers MB, Henninger GR (1981) Cerobrospinal fluid homovanillic acid patterns during treatment. Psychiatr Res 4: 285–290

    Article  Google Scholar 

  • Bowers MB, Rozitis A (1974) Regional differences in homovanillic acid concentrations after acute and chronic administration of antipsychotic drugs. J Pharm Pharmacol 26: 743–745

    Article  PubMed  CAS  Google Scholar 

  • Bunney BS, Grace AA (1978) Acute and chronic haloperidol treatment: comparison of effects on nigral dopaminergic cell activity. Life Sci 23: 1715–1729

    Article  PubMed  CAS  Google Scholar 

  • Chouinard G, Annable L, Jones BD, Collu R (1981) Lack of tolerance to long-term neuroleptic- treatment in dopamine tuberoinfundibular system. Acta Psychiatr Scand 64: 353–362

    Article  PubMed  CAS  Google Scholar 

  • Costa E, Cheney DL, Mao CC, Moroni F (1978) Action of antischizophrenic drugs on the metabolism of y-aminobutyric acid and acetylcholine in globus pallidus, striatum and n. accumbens. Fed Proc 37: 2408–2414

    PubMed  CAS  Google Scholar 

  • Creese I, Burt DR, Snyder SH (1976) Dopamine receptor binding predicts clinical pharmacological potencies of antischizophrenic drugs. Science 192: 481–483

    Article  PubMed  CAS  Google Scholar 

  • Davis JM, Vogel C, Gibbons R, Pavkovic J, Zhang M (1984) Pharmacoendocrinology of schizophrenia. In: Brown GM (ed) Neuroendocrinology and psychiatric disorders. Raven Press, New York, pp 29–54

    Google Scholar 

  • De Rivera JL, Lal S, Ettigi P, Hontela S, Muller HF, Friesen HG (1976) Effect of acute and chronic neuroleptica therapy on serum prolactin levels in men and women of different age groups. Clin Endocrinol 5: 273–282

    Article  CAS  Google Scholar 

  • Emrich H, Höllt V, Bergman M, Kissling M, Schmid W, Zerssen D, Herz A (1980) Plasma levels of beta-endorphine in schizophrenic patients. In: Costa E, Tabucchi M (eds) Neuropeptides and neuronal communications. Raven Press, New York, pp 489–502

    Google Scholar 

  • Freemann AS, Bunney BS (1987) Chronic neuroleptic effects on dopamine neuron activity: a model for predicting therapeutic efficacy and side effects? In: Dahl SG, Gram LF, Paul SM, Potter Z (eds) Clinical pharmacology in psychiatry (Psychopharmacology Serie 3 ). Springer, Berlin Heidelberg New York Tokyo, pp 223–235

    Google Scholar 

  • Langer DH, Brown GL, Docherty JP (1981) Dopamine receptors supersensitivity and schizophrenia: a review. Schizophr Bull 7 (2): 208–224

    PubMed  CAS  Google Scholar 

  • Mackaya VP, Doble A, Bird ED, Spokes EG, Quik M, Iversen LL (1978) 3H-spiroperone binding in normal and schizophrenic post mortem human brain. Life Sci 23: 527–532

    Article  Google Scholar 

  • Meltzer HY, Fang VS (1976) The effect of neuroleptics on serum prolactin in schizophrenic patients. Arch Gen Psychiatry 33: 279–286

    Article  PubMed  CAS  Google Scholar 

  • Meltzer HY, Busch D, Fang VS (1981) Hormones, dopamine receptors and schizophrenia. Psychoneuroendocrino logy 6: 17–36

    Article  CAS  Google Scholar 

  • Meltzer HY, Goode DJ, Fang VS (1978) The effect of psychotropic drugs on endocrine function. I. Neuroleptics, precursors and agonists. In: Lipton MA, Mascio AD, Killam KF (eds) Psychopharmacology: a generation of progress. Raven Press, New York, pp 509–529

    Google Scholar 

  • Meltzer MY, Stahl SM (1976) The dopamine hypothesis of schizophrenia: a review. Schizophr Bull 2: 19–24

    PubMed  CAS  Google Scholar 

  • Muller P, Seeman P (1978) Brain neurotransmitter receptors after long-term haloperidol: dopamine, acetylcholine, serotonin, alpha-noradrenergic and naxalone receptors. Life Sci 21: 1751–1758

    Article  Google Scholar 

  • Müller-Spahn F, Ackenheil M, Albus M, May G, Welter D, Zander K (1984) Neuroendocrine effects of apomorphine in chronic schizophrenic patients under long-term neuroleptic therapy and after drug withdrawal. Relations to psychopathology and tardive dyskinesia. Psychopharmacology 84. 436–440

    Article  PubMed  Google Scholar 

  • Müller-Spahn F, Ackenheil M, Albus M, Botschev C, Naber D, Welter D (1986) Neuroendocrine effects of clonidine in chronic schizophrenic patients under long-term neuroleptic therapy and after drug withdrawal: relations to psychopathology. Psychopharmacology 88: 190–195

    Article  PubMed  Google Scholar 

  • Naber D, Fischer H, Ackenheil M (1979) Effect of long-term neuroleptic treatment on dopamine tuberoinfundibular system: development of tolerance? Commun Psychopharmacol 3: 59–65

    PubMed  CAS  Google Scholar 

  • Nathan RS, Sachar EJ, Ostrow L, Asnis GM, Halbreich U, Halpern FS (1981) Failure of dopaminergic blockade to affect prolactin, growth hormone and cortisol responses to insulin-induced hypoglycemia in schizophrenics. J Clin Endocrinol Metab 52: 807–809

    Article  PubMed  CAS  Google Scholar 

  • Nedopil N, Weiss-Brummer I, Rüther E (1984) Neuroendocrine changes during the course of neuroleptic treatment of schizophrenic patients. In: Shah N, Donald GA (eds) Psychoneuroendocrine dysfunction. Plenum Medical Book, New York, pp. 583–597

    Google Scholar 

  • Pickar D, Labarca R, Doran AR, (1985) Longitudinal measurement of plasma homovanillic acid levels in schizophrenic patients: Correlation with psychosis and response to neuroleptic treatment. Arch Gen Psychiatry 43: 669–676

    Article  Google Scholar 

  • Owen F, Crow TJ, Poulter, Cross AJ, Longden A, Riley GJ (1978) Dopamine-receptor sensitivity in schizophrenia. Lancet II: 223–226

    Article  Google Scholar 

  • Reynolds GP, Rieders P, Jellinger K, Gabriel E (1981) Dopamine receptors and schizophrenia — the neuroleptic drug problem. Neuropharmacology 20: 1319–1320

    PubMed  CAS  Google Scholar 

  • Rubin RT, Hays SE (1979) Variability of prolactin response to intravenous and intramuscular haloperidol in normal adult men. Psychopharmacology 61: 17–24

    Article  PubMed  CAS  Google Scholar 

  • Rüther E (1986) Wirkungsverlauf der neuroleptischen Therapie: Verlaufsuntersuchungen bei der antipsychotischen Therapie mit Haloperidol and Clozapin. Fischer, Stuttgart

    Google Scholar 

  • Sarafoff M, Davis L, Rüther E (1979) Clozapine induced increase of human plasma norepinephrine. J Neurol Trans 46: 145–180

    Article  Google Scholar 

  • Sedvall G (1980a) Concentrations of monoamine metabolites and chlorpromazine in cerebrospinal fluid for prediction of therapeutic response in psychotic patients treated with neuroleptic drugs. Prog Biochem Pharmacol 16: 133–140

    CAS  Google Scholar 

  • Sedvall G (1980b) Relationships among biochemical, clinical and pharmaco kinetic variables in neuroleptic treated schizophrenic patients. In: Cattabeni F et al. (eds) Long-term effects of neuroleptics. Adv Biochem Psychopharmacol 24: 521–528

    Google Scholar 

  • Westerink BHC, Korf J (1975) Influence of drugs on striatal and limbic homovanillic acid concentration in the rat brain. Eur J Pharmacol 33: 31–40

    Article  PubMed  CAS  Google Scholar 

  • Sternberg DE, Charney DS, Henninger GR, Leckmann IJ, Hafstad KM, Landis DH (1982) Impaired presynaptic regulation of norepinephrine in schizophrenia. Arch Gen Psychiatry 39: 285–289

    Article  PubMed  CAS  Google Scholar 

  • Wode-Helgodt B, Eneroth P, Fryö B, Gullberg B, Sedvall G (1977) Effect chlorpromazine treatment on prolactin levels in cerebrospinal fluid and plasma of psychotic patients. Acta Psychiatr Scand 58: 280–293

    Article  Google Scholar 

  • Zander KJ, Fisher B, Zimmer R, Ackenheil M (1981) Long-term neuroleptic treatment of chronic schizophrenic patients. Clinical and biochemical effects of withdrawal. Psychopharmacology 73: 43–47

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. E. Rüther
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. Müller-Spahn
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. 24, rue des Fossés Saint Jacques, F-75005, Paris, France

    Pierre Pichot

  2. Psychiatrische Klinik der Technischen Universität, Ismaninger Str. 22, D-8000, München 80, Deutschland

    Hans-Jürgen Möller

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Rüther, E., Müller-Spahn, F. (1987). Neurobiochemische Untersuchungen bei Akut- und Langzeitbehandlung mit Neuroleptika. In: Pichot, P., Möller, HJ. (eds) Neuroleptika Rückschau 1952–1986, Künftige Entwicklungen. Tropon-Symposium, vol 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-83188-1_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-83188-1_4

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-18197-2

  • Online ISBN: 978-3-642-83188-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation